Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/25/2010US20100298326 Carboxamide compounds and their use as calpain inhibitors
11/25/2010US20100298325 Pyridine derivatives for the treatment of amyloid-related diseases
11/25/2010US20100298324 Prolyl Hydroxylase Inhibitors
11/25/2010US20100298323 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/25/2010US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
11/25/2010US20100298321 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
11/25/2010US20100298320 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
11/25/2010US20100298319 Pyrimidine substituted purine derivatives
11/25/2010US20100298318 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
11/25/2010US20100298317 Method of treating polycystic kidney diseases with ceramide derivatives
11/25/2010US20100298316 Benzothiazoles Having Histamine H3 Receptor Activity
11/25/2010US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors
11/25/2010US20100298314 Novel jnk inhibitors
11/25/2010US20100298313 Method of using imidazolothiazole compounds for the treatment of disease
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298311 Tetrahydronaphthalene derivates, process for preparing them and their use as antiinflammatory agents
11/25/2010US20100298310 Thiazole Derivatives as Kinase Inhibitors
11/25/2010US20100298309 Tricyclic triazolic compounds
11/25/2010US20100298308 Compositions and methods for bone formation and remodeling
11/25/2010US20100298307 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
11/25/2010US20100298306 (1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease
11/25/2010US20100298305 Tizanidine for the treatment of post-traumatic stress disorder and nightmares
11/25/2010US20100298304 Diagnosis and treatment of autism spectrum disorders
11/25/2010US20100298303 Cgrp receptor antagonists
11/25/2010US20100298302 Novel protein kinase modulators
11/25/2010US20100298301 Oxazole tyrosine kinase inhibitors
11/25/2010US20100298300 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
11/25/2010US20100298299 non-peptide derivatives as bradykinin b1 antagonists
11/25/2010US20100298298 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
11/25/2010US20100298297 Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof
11/25/2010US20100298296 Oligomer-Tricyclic Conjugates
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298294 Ketone bodies and ketone body esters as blood lipid lowering agents
11/25/2010US20100298293 Substituted oxazolidinones and their use
11/25/2010US20100298292 Modulators of 5-ht receptors and methods of use thereof
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100298290 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298288 Cetp inhibitors derived from benzoxazole arylamides
11/25/2010US20100298287 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
11/25/2010US20100298286 Organic Compounds
11/25/2010US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/25/2010US20100298284 Benzamides and related inhibitors of factor xa
11/25/2010US20100298283 Pharmaceutical composition for enhancing immunity, and extract of poria
11/25/2010US20100298282 Treatment of Ocular Conditions and the Side-Effects of Glucocorticoids
11/25/2010US20100298281 Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer
11/25/2010US20100298280 Compounds for the Modulation of Huntingtin Aggregation, Methods and Means for Identifying Such Compounds
11/25/2010US20100298279 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100298277 Angiotensin ii receptor antagonists
11/25/2010US20100298276 Thyroid receptor ligands
11/25/2010US20100298274 Fat containing composition
11/25/2010US20100298273 Lipid mixture for infant nutrition
11/25/2010US20100298272 Phosphorus containing heterocyclic compounds, sugar analogues, and compositions having anti-cancer activity containing the same
11/25/2010US20100298271 Compounds for use in the treatment of cancer
11/25/2010US20100298270 Novel Compounds and Methods of Using Them
11/25/2010US20100298269 Prodrugs of cgrp receptor antagonists
11/25/2010US20100298268 Controlled release formulations of levodopa and uses thereof
11/25/2010US20100298266 Hydroxyethylstarch
11/25/2010US20100298265 Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin
11/25/2010US20100298264 Biodegradable and water-soluble hemostatic material and a method for preparing the same
11/25/2010US20100298263 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
11/25/2010US20100298262 Process for the ultrapurification of alginates
11/25/2010US20100298261 Edible compositions for lowering cholesterol
11/25/2010US20100298260 Non-anticoagulant polysaccharide compositions
11/25/2010US20100298259 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/25/2010US20100298258 Analgesic compositions
11/25/2010US20100298257 Nucleoside phosphoramidates
11/25/2010US20100298256 Antiviral compounds
11/25/2010US20100298255 Methods for providing personalized medicine test ex vivo for hematological neoplasms
11/25/2010US20100298254 Organ arrest, protection and preservation
11/25/2010US20100298253 Pharmaceutical Compositions Comprising Forms of 5-Azacytidine
11/25/2010US20100298252 Methods and compositions for ophthalmic treatment of fungal and bacterial infections
11/25/2010US20100298251 Wound-healing agent containing momordicae semen extract
11/25/2010US20100298250 Compositions and methods for extracting and using phytochemicals for the treatment of influenza
11/25/2010US20100298249 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/25/2010US20100298248 Biologically active macrolides, compositions, and uses thereof
11/25/2010US20100298246 Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same
11/25/2010US20100298245 Pharmaceutical Composition for the Treatment of IL-8 mediated diseases
11/25/2010US20100298244 Composition for the prevention and the treatment of helicobacter pylori infection
11/25/2010US20100298243 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
11/25/2010US20100298242 Masking the taste of compositons containing salt
11/25/2010US20100298237 Use of hdac inhibitors for treatment of cardiac rhythm disorders
11/25/2010US20100298230 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
11/25/2010US20100298226 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
11/25/2010US20100298221 2-phenoxy nicotine acid derivative and use thereof
11/25/2010US20100298214 Treatment of autoimmune disease
11/25/2010US20100298209 Compounds for preventing or treating a viral infection
11/25/2010US20100298206 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
11/25/2010US20100298205 Methods and compositions for the treatment of conditions related to gastric acid secretion
11/25/2010US20100298203 Sdf-i-based glycosaminoglycan antagonists and methods of using same
11/25/2010US20100298202 Bri polypeptides and reducing ab aggregation
11/25/2010US20100298200 Compounds and assays for controlling Wnt activity
11/25/2010US20100298138 Aminoazoline and Urea Derivatives for Combating Animal Pests
11/25/2010US20100297665 Method for testing and screening p38 map kinase modifiers
11/25/2010US20100297615 Egfr mutations
11/25/2010US20100297274 Cocoa extracts for use in providing skin benefits
11/25/2010US20100297271 Compositions and methods for reducing hepatotoxicity associated with drug administration
11/25/2010US20100297269 Compositions for intranasal administration
11/25/2010US20100297267 Compositions for diabetes treatment and prophylaxis
1 ... 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 ... 7860